Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Purity | ≥98% |
|---|---|
| Formula | C18H18O4 |
| Formula Wt. | 298.33 |
| IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
| Appearance | White Crystal Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
α1-adrenergic antagonist.
Metabolite of clofibrate; PPARα agonist.
Cdc42 GTPase inhibitor.
1,8-Diaza-anthracene-tetrone; JNK and ERK5 inhi...
LRRK2 inhibitor.
Cephalosporin analogue
Azapirone; α1-adrenergic and 5-HT1A partial ag...
Endogenous steroid hormone involved in immune r...
Synthetic analog of 1,4-naphthoquinone, precurs...
Synthetis peptide, melanocortin analog; MCR ago...
MEK1/2 inhibitor.
Statin, naturally produced by mushrooms; HMG-Co...
Octapeptide derived from activity-dependent neu...
FLT3, PDGFR, c-Kit inhibitor.
β-lactamase inhibitor.
Dipeptide.
SIRT inhibitor.
Byproduct of L-arginine metabolism found in wat...
Extract containing catechins and flavonoids fou...